1672-1535
2005 Issue 3
..............page:231
..............page:186
..............page:英文目录前
..............page:英文目录前
..............page:220
ru xian ai nei fen mi zhi liao de xian zhuang yu jin zhan
cheng guang yuan
cheng guang yuan
..............page:287-292
di wei mds de zhi liao jin zhan
chen shu chang
chen shu chang
..............page:282-286,292
fei xiao xi bao fei ai de hua liao jin zhan
wang meng zhao
wang meng zhao
..............page:279-281
..............page:276-278
Combination of Kanglaite injection and chemotherapy for treatment of advanced non-small cell lung cancer
Wang Yuling;Li Daoming;Xu Hong;TAO Min;Wang Qingcai
Wang Yuling;Li Daoming;Xu Hong;TAO Min;Wang Qingcai
..............page:274-275,273
High potency and specific anti- tumor immunoreaction induced by dendritic cells and heat shock tumor antigen
Wang Ailin;Ju Xiaohong;Meng Fanjun
Wang Ailin;Ju Xiaohong;Meng Fanjun
..............page:270-273
Emodin inhibits prostate cancer cell growth in vivo by suppressing androgen receptor expression
Qiu Lin;Cha Tailung;WEN Yong;Chen Junde;Ma Jun;Hung Mingqi
Qiu Lin;Cha Tailung;WEN Yong;Chen Junde;Ma Jun;Hung Mingqi
..............page:265-269,264
Construct a full-length mRNA for the human mutidrug resistance gene by method of transcribed in vitro
Qian Haipeng;Xiang Yang;Tian fang;Li Lei
Qian Haipeng;Xiang Yang;Tian fang;Li Lei
..............page:261-264
Second primary carcinoma in patients with squamous cell carcinoma of tongue
LI Zhengjiang;Tang Pingzhang;Xu Zhengang;Zhang Zongmin;Wen Kexin
LI Zhengjiang;Tang Pingzhang;Xu Zhengang;Zhang Zongmin;Wen Kexin
..............page:257-260
Serum tumor biomarkers associated with lung cancer
luo su xia ; chen xiao bing ; xiao yi jun ; wang rui lin
luo su xia ; chen xiao bing ; xiao yi jun ; wang rui lin
..............page:252-256
The application of cytometric DNA analysis in the diagnosis of malignant pleural effusions
Fan Ying;LI Longyun
Fan Ying;LI Longyun
..............page:249-251,248
Current status and prospect of therapy for colorectal cancer metastatic to the liver
Zhou Jiaolin;Qiu Huizhong
Zhou Jiaolin;Qiu Huizhong
..............page:243-248
Latest developments in chemotherapy for patients with relapsed or refractory non-small cell lung cancer
Wang Hong yu;Zhang Xiangru;QU Fenglian;CHU Datong;Sun Yan
Wang Hong yu;Zhang Xiangru;QU Fenglian;CHU Datong;Sun Yan
..............page:237-242
Progress in adjuvant chemotherapy of patients with node- positive breast cancer
Zhao Weihong;Xu Binghe
Zhao Weihong;Xu Binghe
..............page:232-236
Progress in the adjuvant therapy of node-negative breast cancer patients
Liao Yuqian;Xu Binghe
Liao Yuqian;Xu Binghe
..............page:227-231
The DNA repair mechanisms and its role in the development and progression of MDS
Niu Yi;CHEN Shuchang
Niu Yi;CHEN Shuchang
..............page:221-226
gu sui zeng sheng yi chang zong he zheng de ba xiang zhi liao
shao ya juan ; chen shu chang ; li rong sheng
shao ya juan ; chen shu chang ; li rong sheng
..............page:215-220
EGFR inhibitors in breast cancer
Yuan Peng;Xu Binghe
Yuan Peng;Xu Binghe
..............page:212-214,281
Primary bilateral breast cancer
Lin Yan;Zhou Yidong;Sun Qiang;Huang Huanyuan
Lin Yan;Zhou Yidong;Sun Qiang;Huang Huanyuan
..............page:207-211
Tumor markers in renal cell carcinoma
Qiao Mingzhou;LI Changling
Qiao Mingzhou;LI Changling
..............page:202-206
Preoperative radiotherapy and neoadjuvant chemotherapy in invasive bladder cancer
Qiao Mingzhou;LI Changling
Qiao Mingzhou;LI Changling
..............page:198-201,190
Current status and research advances on androgen independent prostate cancer
Shou Jianzhong;LI Changling
Shou Jianzhong;LI Changling
..............page:191-197,242
The progress of neoadjuvant hormonal therapy before radical prostatectomy
Guan Kaopeng;LI Changling
Guan Kaopeng;LI Changling
..............page:187-190
mi niao nan sheng zhi xi tong zhong liu
li chang ling
li chang ling
..............page:185-186